Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04319757
Title ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Acepodia Biotech Inc.
Indications

Advanced Solid Tumor

breast cancer

endometrial cancer

stomach cancer

Therapies

ACE1702 + Cyclophosphamide + Fludarabine

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.